Gleevec(Registered tradmark) in the Treatment of Inflammatory Arthritis

摘要

Tyrosine Kinase inhibitors are an area of rapidly evolving medications in Rheumatoid Arthritis. There is currently no information beyond case reports and thus a retrospective review of a large database of records of patients could yield additional insight about the true efficacy of Gleevec in treating inflammatory arthritis. While 13 records were identified in the search of M2 requested by this protocol, only 2 records had enough information in AHLTA for a meaningful review. Of these 2, only 1 satisfied the search criteria but only partial records were available.